Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Womens Health (Larchmt) ; 19(8): 1561-7, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20575712

ABSTRACT

OBJECTIVE: The aim of this study is to evaluate the use and acceptability of Carraguard among men and women enrolled as couples in a microbicide trial. MATERIALS AND METHODS: Focus groups were conducted with participants in a 6-month randomized, placebo-controlled trial that enrolled sexually active, low-risk couples in Thailand. Participants were blinded as to which gel they had received at the time of the discussions. RESULTS: Most men and women liked the gel and found it acceptable. The majority of men and women thought that using the gel increased sexual pleasure, although participants disagreed about whether using the gel increased sexual frequency. Drawbacks of gel use included that it was too wet or messy, and nearly all respondents thought that the applicator was too hard. Most men and women questioned the utility of using the gel among married couples since gel use was tied to perception of HIV/STI risk. However, those who perceived themselves to be at risk expressed interest in using the product as an alternative to condoms. Many women were particularly interested in a product that also had contraceptive properties. Gel use also raised issues of trust and fidelity among couples and questions about men's ability to detect women's use of the product. CONCLUSION: Men and women in this study found the gel acceptable and thought that it should be made available if it is found to be safe and effective. Strategies for marketing a potential microbicide product must take the target population into consideration. For married couples, key considerations may be partner dynamics and trust issues, whereas messages focusing on sexual pleasure or disease prevention may resonate more strongly with sex workers or other populations.


Subject(s)
Carrageenan , Patient Acceptance of Health Care , Personal Satisfaction , Sexual Partners/psychology , Sexually Transmitted Diseases/prevention & control , Vaginal Creams, Foams, and Jellies , Adult , Disease Transmission, Infectious/prevention & control , Double-Blind Method , Female , Focus Groups , Humans , Male , Marketing , Risk-Taking , Sexually Transmitted Diseases/transmission , Thailand
2.
Obstet Gynecol ; 110(6): 1379-88, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18055735

ABSTRACT

OBJECTIVE: Advance provision of emergency contraception can circumvent some obstacles to timely use. We performed a meta-analysis to summarize randomized controlled trials evaluating advance provision of emergency contraception to explore effects on pregnancy rates, sexually transmitted infections, and sexual and contraceptive behaviors. DATA SOURCES: In August 2006, we searched CENTRAL, EMBASE, POPLINE, MEDLINE, a specialized emergency contraception article database, and contacted experts to identify published or unpublished trials. METHODS OF STUDY SELECTION: We included randomized controlled trials comparing advance provision to standard access, defined as any of the following: counseling (with or without information about emergency contraception) or provision of emergency contraception on request at a clinic or pharmacy. TABULATION, INTEGRATION AND RESULTS: Two reviewers independently assessed study quality. We performed a meta-analysis using Review Manager software. Eight randomized controlled trials met inclusion criteria, representing 6,389 patients in the United States, China, and India. Advance provision did not decrease pregnancy rates, despite increased use (single use, odds ratio [OR] 2.52, 95% confidence interval [CI] 1.72-3.70; multiple use: OR 4.13, 95% CI 1.77-9.63) and faster use (weighted mean difference -14.6 hours, 95% CI -16.77 to -12.4 hours). Advance provision did not increase rates of sexually transmitted infections (OR 0.99, 95% CI 0.73-1.34), unprotected intercourse, or changes in contraceptive methods. Women who received emergency contraception in advance were as likely to use condoms as other women. CONCLUSION: Advance provision of emergency contraception did not reduce pregnancy rates and did not negatively affect sexual and reproductive health behaviors and outcomes compared with conventional provision. LEVEL OF EVIDENCE: III.


Subject(s)
Contraception, Postcoital/methods , Contraceptives, Postcoital/administration & dosage , Self Administration , Female , Humans , Odds Ratio , Pregnancy , Pregnancy Rate , Randomized Controlled Trials as Topic , Treatment Outcome
3.
Contraception ; 74(3): 264-71, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16904422

ABSTRACT

OBJECTIVE: This study analyzes the use patterns of , an English-, Spanish-, Arabic- and French-language web site dedicated to three methods of early pregnancy termination: mifepristone/misoprostol, methotrexate/misoprostol and misoprostol alone. METHODS: This study examines both the overall and language-specific use patterns of the web site from October 1, 2004, through September 30, 2005. Data were recorded using Wusage 8.0, a web site statistics program. RESULTS: Over the 12-month study period, received more than 78,000 visits and nearly 240,000 page requests. The English version is the most popular version of the web site (accessed in 46.1% of all visits), followed by the Spanish (35.0%), Arabic (10.4%) and French (8.8%) versions. Spanish-language visits are nearly three times as likely to access the misoprostol-only section of the web site when compared with the other language versions (p<.001). CONCLUSION: This study confirms that multilingual, medically accurate online resources have the potential to expand information about medication abortion to both providers and women considering the option of abortion in diverse communities. Analysis of the language-specific use patterns highlights the different priorities of various types of web site visitors and suggests future priorities for educational outreach, collaboration and research.


Subject(s)
Abortion, Induced , Information Services/statistics & numerical data , Internet/statistics & numerical data , Language , Abortifacient Agents/administration & dosage , Abortion, Induced/methods , Female , Humans , Methotrexate/administration & dosage , Mifepristone/administration & dosage , Misoprostol/administration & dosage , Pregnancy
4.
Eur J Contracept Reprod Health Care ; 11(4): 285-90, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17484194

ABSTRACT

OBJECTIVES: To collect information about how private physicians in South Africa provide medication abortion services to their patients. METHODS: In April 2003 we asked physicians in private practice in South Africa who had purchased mifepristone (Mifegyne) from the South African distributor about the medication abortion regimen they offered, satisfaction with the method, and how services have been incorporated into their practices. RESULTS: Forty-four providers participated in the survey. They report using a range of doses and regimens. Most respondents offer mifepristone-misoprostol to their patients, although a significant minority also offer misoprostol-alone for pregnancy termination. While the majority of medication abortion providers also offer surgical abortions, a significant number of non-surgical providers were only offering medication abortion. CONCLUSION: South African medication abortion providers find the method acceptable, indicate that their staff are largely supportive of offering it to their patients, and report that clients like the method. Those surveyed believe that most of their patients are eligible for the regimen, although uptake has been limited.


Subject(s)
Abortifacient Agents/therapeutic use , Abortion, Induced/statistics & numerical data , Health Services Accessibility , Practice Patterns, Physicians' , Women's Health Services , Female , Gynecology , Humans , Mifepristone/therapeutic use , Misoprostol/therapeutic use , Pregnancy , Private Practice , South Africa
5.
Womens Health Issues ; 15(4): 174-8, 2005.
Article in English | MEDLINE | ID: mdl-16051108

ABSTRACT

BACKGROUND: Access to emergency contraception (EC) is an important option for women wanting to prevent an unintended pregnancy. In California, emergency rooms (ERs) are required to provide survivors of sexual assault with information about and access to EC. This study assessed the likelihood that a woman calling a Catholic hospital in California to inquire about EC could access the medication. METHODS: During September 2003, we contacted an ER staff member in each of California's Catholic hospitals (n = 45) using a mystery caller approach. Following a written script, trained female researchers asked ER staff whether they dispense EC at their facility and under what circumstances. If respondents initially stated that their facility would not dispense EC, the caller asked whether EC was available to women who had been raped. If staff confirmed that their facility would not provide EC under any circumstances including rape, callers requested a referral to another facility that would provide the medication. RESULTS: Sixty-six percent of staff contacted stated that their hospital would not provide EC under any circumstances, including rape. Of those that would not dispense EC, fewer than half of respondents (48%) provided a referral. Of the 14 referrals given, only about one third (n = 5) led to a facility that provides EC. CONCLUSIONS: Our findings suggest that access to EC in California's Catholic hospitals is minimal, even for victims of sexual assault. As many as two-thirds of these hospitals may be violating state legislation requiring hospitals to provide EC to sexual assault survivors upon request.


Subject(s)
Catholicism , Contraception, Postcoital/statistics & numerical data , Contraceptives, Postcoital/supply & distribution , Emergency Service, Hospital/statistics & numerical data , Health Services Accessibility/statistics & numerical data , Hospitals, Religious/statistics & numerical data , Religion and Medicine , Women's Health Services/supply & distribution , California , Emergency Service, Hospital/legislation & jurisprudence , Female , Health Care Surveys , Hospitals, Religious/legislation & jurisprudence , Humans , Interviews as Topic , Rape/statistics & numerical data , Referral and Consultation/legislation & jurisprudence , Referral and Consultation/statistics & numerical data , Surveys and Questionnaires , Women's Health Services/legislation & jurisprudence
6.
Contraception ; 69(1): 59-62, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14720622

ABSTRACT

Our study explored a largely unacknowledged obstacle to abortion access in Massachusetts: the unwillingness of nurses to staff abortion procedures. Evidence suggests that nurses tend to be more likely to oppose abortion than other medical professionals. However, the attitudes and practices of hospital-based nurses regarding abortion have not been thoroughly investigated. We collected qualitative information from physicians and nurse managers to understand how nurses' attitudes affect hospital-based abortion services in Massachusetts. We surveyed key respondents at all hospitals in Massachusetts where abortion services are available to any woman who requests them. Of the 20 individuals who responded (87%), 17 were physicians and 3 were nurse managers. We found that over half of physician respondents believed that the unavailability or unwillingness of nurses to staff abortions is a slight or moderate problem, and nearly a quarter of physician respondents characterized it as a large or very large problem. Thus, nurses' attitudes towards abortion and their unwillingness to assist with procedures may hinder patient access to abortion services.


Subject(s)
Abortion, Legal/psychology , Attitude of Health Personnel , Nursing Staff, Hospital/psychology , Female , Humans , Massachusetts , Pregnancy , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...